MEDICAL DEVICE OEM — CONTRAST MEDIA/INJECTORS
E-Replenishment of contrast media leading to “Injection as-a-Service”
Before CCS
- No visibility of location, usage and condition of devices
- Losing aftermarket revenue of service and supplies to competition due to lack of visibility and control of devices/partners
- Reactive based on customer/partner needs
Post CCS
- Obtained full visibility of location, usage, status of devices/customers
- Offered e-Replenishment of contrast media as-a-Service (JIT inventory based on usage)
- Demand-based revenue prediction
- Remote fault detection and monitoring of MTBF/MTTR to monitor 3rd party service partners’ performance
- Eventually move to an “injection as a service” business model
